Drug target · DRD3
D3
Dopamine D3 receptor
1 compound in the CNS pipeline acts on D3.
Compounds targeting D3
| Compound | Action | Affinity | Lead program | Developer |
|---|---|---|---|---|
| Rotigotine extended-release microspheres (LY03003)primarySmall molecule | Agonist | Ki 0.71 nM | ApprovedParkinson's disease | Luye Pharma Group Ltd. |